The Yale team used a combination of neuroimaging, computational neurobiology, and pharmacological techniques to reveal functioning at both the cellular level and across larger brain regions.
In a paper in Proceedings of the National Academy of Sciences the week of 24 September 2012, Yale scientists use this approach to show that a disruption of a particular signaling mechanisms within larger neural systems may be contribute to schizophrenia symptoms.
Source: Yale University
